http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11331293-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_80eb35630ae5a11f603db5175804fe2d |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-198 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-198 |
| filingDate | 2022-01-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e7f880e56b846a2ccd4700ccce4a57e5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_03c8e17031515ff936b8acceea1c0c05 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b8e42f1d20039b72483a2e5f7f23ef2 |
| publicationDate | 2022-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-11331293-B1 |
| titleOfInvention | Method for treatment of Parkinson's disease |
| abstract | Disclosed is a method for the treatment of a neurological or movement disorder, e.g., Parkinson's disease, in an individual in need thereof, by parenteral administration of levodopa and a dopa decarboxylase inhibitor (DDCI), such as carbidopa, benserazide or any combination thereof, concomitantly with oral administration of levodopa, a DDCI, such as carbidopa, benserazide, or any combination thereof. |
| priorityDate | 2020-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 202.